-  - Zm. - Wolumen Bid- Ask- Kapitalizacja Rynkowa St. dywidendy Wskaźnik C/Z
-EUR - -
Obrót: -
-Wolumen Bid: - -Wolumen Ask: - 38,47 mldEUR - -

Opis działalności

Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We harness science and technology to create products that support safer and healthier living and that enhance the overall quality of life. Not only is the company a custom manufacturer and developer, Lonza also offers services and products ranging from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers, from the vitamin B3 compounds and organic personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens. Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 40 major manufacturing and R&D facilities.
 

Zarząd & Rada nadzorcza

CEO
Albert M. Baehny
Zarząd
Jean-Marc Huët, Philippe Deecke, Caroline Barth, Gordon Bates, Jean-Christophe Hyvert, Maria Soler Nunez, Christian Seufert, Daniel Palmacci
Rada nadzorcza
Angelica Kohlmann, Barbara M. Richmond, Christoph Mäder, Juergen B. Steinemann, Olivier Verscheure, Roger Nitsch, Marion Helmes
 

Dane firmy

Nazwa: Lonza Group AG
Adres: Münchensteinerstraße 38,Basel
Telefon: +41-61-31681-11
Fax: +41-61-31691-11
E-mail: info@lonza.com
Internet: www.lonzagroup.com/
Przemysł: Surowce naturalne
Sektor: Chemia
Podsektor: -
Koniec roku finansowego: 31.12
Free float: 99,70%
Data IPO: 02.11.1999

Relacje inwestorskie

Nazwa: Lyle Wheeler
Telefon: +41 79 154 9522
Fax: -
E-mail: investor.relations@lonza.com

Kalendarz korporacyjny

Tydz. 30 | 25.07.2024 Raport okresowy/2. kwartał
 

Główni akcjonariusze

Inne
 
83,90%
BlackRock, Inc
 
9,85%
UBS Fund Management (Switzerland) AG
 
6,25%